Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.

Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.

Veure altres versions (1)

A small but variable subgroup of patients with myasthenia gravis (MG) who have antibodies to muscle-specific kinase (MuSKAb-MG) can present with distinct phenotypes and are often treatment-resistant. The prevalence, clinical phenotypes and outcomes of treatment of patients with MuSKAb-MG in Thailand...

Descripció completa

Dades bibliogràfiques
Autors principals:	Witoonpanich, R, Dejthevaporn, C, Pulkes, T, Tunlayadechanont, S, Boonkongchuen, P, Pongpakdee, S, Vincent, A
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand
per: Witoonpanich, R, et al.
Publicat: (2013)

A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
per: Keritam, O, et al.
Publicat: (2024)

Antibodies against muscle-specific kinase in juvenile myasthenia gravis.
per: Anlar, B, et al.
Publicat: (2003)

Radiological Characteristics of Extraocular Muscles in Myasthenia Gravis Patients with Ocular Manifestations: A Case–Control Study
per: Lueangaram S, et al.
Publicat: (2021-06-01)

A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
per: Omar Keritam, et al.
Publicat: (2024-12-01)

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2005)

Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment
per: Michelangelo Cao, et al.
Publicat: (2020-09-01)

Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
per: Farrugia, M, et al.
Publicat: (2006)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
per: Vincent, A, et al.
Publicat: (2006)

[Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis]
per: Tan, Y, et al.
Publicat: (2021)

Facial muscle atrophy in musk antibody positive myasthenia gravis
per: Farrugia, M, et al.
Publicat: (2006)

Simultaneous Presence of Acetylcholine Receptor and Muscle Specific Tyrosine Kinase Antibodies in Myasthenia Gravis
per: Maryam Poursadeghfard, et al.
Publicat: (2019-12-01)

Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature
per: Ken-ichi Inoue, et al.
Publicat: (2020-03-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
per: Koneczny, I, et al.
Publicat: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
per: Koneczny, I, et al.
Publicat: (2014)

Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise
per: Hassam Ali, et al.
Publicat: (2021-01-01)

An experimental mouse model of musk antibody positive myasthenia gravis
per: Viegas, S, et al.
Publicat: (2008)

Facial and bulbar muscle atrophy in acetylcholine receptor antibody-positive myasthenia gravis
per: Ronnyson Susano Grativvol, et al.

Myasthenia gravis with MuSK antibodies
per: Farrugia, M, et al.
Publicat: (2005)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
per: Takata, K, et al.
Publicat: (2019)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
per: Lee, J, et al.
Publicat: (2006)

Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis
per: Hu G, et al.
Publicat: (2024-12-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
per: Farrugia, M, et al.
Publicat: (2007)

Myasthenia gravis
per: Vincent, A
Publicat: (2007)

Antibodies in myasthenia gravis and related disorders.
per: Vincent, A, et al.
Publicat: (2003)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2002)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2004)

Antibodies to AChRs in seronegative myasthenia gravis
per: Leite, M, et al.
Publicat: (2006)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2001)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
per: Nilesh Wagh, et al.
Publicat: (2024-09-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
per: Chang, T, et al.
Publicat: (2009)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
per: Vincent, A, et al.
Publicat: (2008)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
per: Hoch, W, et al.
Publicat: (2001)

Autoimmune myasthenia gravis.
per: Jayawant, S, et al.
Publicat: (2013)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
per: Diana Epure, et al.
Publicat: (2016-06-01)

The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis
per: Marcus Magnussen, et al.
Publicat: (2015-01-01)

Seronegative myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2004)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
per: Shiraishi, H, et al.
Publicat: (2005)

Long-term efficacy of non-steroid immunosuppressive agents in anti-muscle-specific kinase positive myasthenia gravis patients: a prospective study
per: Tan, Y, et al.
Publicat: (2022)

Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
per: Ying Tan, et al.
Publicat: (2022-06-01)